US09610B1089 - Common Stock
ONCONETIX INC
NASDAQ:ONCO (6/28/2024, 7:18:42 PM)
After market: 0.164 0 (-1.91%)0.1672
-0.04 (-18.4%)
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The firm has Entadfi, a Food and Drug Administration (FDA) approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. Entadfi is a once-daily, oral treatment for BPH that combines finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. Proclarix is a risk score combining in-vitro assays for the quantitative detection of biomarkers with a proprietary algorithm to assess a patient’s risk of having clinically significant prostate cancer.
ONCONETIX INC
201 E. Fifth Street, Suite 1900
Cincinnati OHIO
P: 15136204101
Employees: 12
Website: https://onconetix.gcs-web.com/
Which stocks are experiencing notable movement on Thursday?
Get insights into the top gainers and losers of Tuesday's pre-market session.
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!
Onconetix just reported results for the first quarter of 2024.
Here you can normally see the latest stock twits on ONCO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: